These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1976419

  • 1. Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.
    Wang XJ, Wang XH, Han JS.
    Brain Res; 1990 Jul 16; 523(1):5-10. PubMed ID: 1976419
    [Abstract] [Full Text] [Related]

  • 2. [Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
    Wang XH, Wang XJ, Han JS.
    Sheng Li Xue Bao; 1990 Jun 16; 42(3):219-25. PubMed ID: 1982023
    [Abstract] [Full Text] [Related]

  • 3. Phorbol ester suppression of opioid analgesia in rats.
    Zhang LJ, Wang XJ, Han JS.
    Life Sci; 1990 Jun 16; 47(19):1775-82. PubMed ID: 1979138
    [Abstract] [Full Text] [Related]

  • 4. [Cholecystokinin-octapeptide antagonizes the central depressive effect of opioid peptides in rats].
    Mei L, Han JS.
    Sheng Li Xue Bao; 1991 Apr 16; 43(2):156-63. PubMed ID: 2068585
    [Abstract] [Full Text] [Related]

  • 5. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
    Wang XJ, Han JS.
    J Neurochem; 1990 Oct 16; 55(4):1379-82. PubMed ID: 2168937
    [Abstract] [Full Text] [Related]

  • 6. Cyclic AMP mediates mu and delta, but not kappa opioid analgesia in the spinal cord of the rat.
    Wang JF, Ren MF, Xue JC, Han JS.
    Life Sci; 1993 Oct 16; 52(24):1955-60. PubMed ID: 8099428
    [Abstract] [Full Text] [Related]

  • 7. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    Hong EK, Takemori AE.
    J Pharmacol Exp Ther; 1989 Nov 16; 251(2):594-8. PubMed ID: 2553928
    [Abstract] [Full Text] [Related]

  • 8. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD, Leslie JB, Su YF, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1987 Jan 16; 240(1):150-8. PubMed ID: 3027302
    [Abstract] [Full Text] [Related]

  • 9. Cholecystokinin octapeptide reverses mu-opioid-receptor-mediated inhibition of calcium current in rat dorsal root ganglion neurons.
    Liu NJ, Xu T, Xu C, Li CQ, Yu YX, Kang HG, Han JS.
    J Pharmacol Exp Ther; 1995 Dec 16; 275(3):1293-9. PubMed ID: 8531095
    [Abstract] [Full Text] [Related]

  • 10. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR, Makhlouf GM.
    Am J Physiol; 1991 Jan 16; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [Abstract] [Full Text] [Related]

  • 11. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
    Omote K, Kitahata LM, Nakatani K, Collins JG.
    Brain Res; 1991 Jul 19; 554(1-2):299-303. PubMed ID: 1657291
    [Abstract] [Full Text] [Related]

  • 12. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ, Stapelfeld A, Rafferty MF, de Costa BR, Rice KC, Hammond DL.
    J Pharmacol Exp Ther; 1991 Nov 19; 259(2):725-31. PubMed ID: 1658309
    [Abstract] [Full Text] [Related]

  • 13. Interaction of cholecystokinin and somatostatin with a selective mu-opioid agonist and mu- and kappa-antagonists in thermoregulation.
    Ghosh S, Geller EB, Adler MW.
    Brain Res; 1997 Jan 16; 745(1-2):152-7. PubMed ID: 9037404
    [Abstract] [Full Text] [Related]

  • 14. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 16; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 15. All three types of opioid receptors in the spinal cord are important for 2/15 Hz electroacupuncture analgesia.
    Chen XH, Han JS.
    Eur J Pharmacol; 1992 Feb 11; 211(2):203-10. PubMed ID: 1319342
    [Abstract] [Full Text] [Related]

  • 16. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Jul 11; 242(1):1-7. PubMed ID: 2886635
    [Abstract] [Full Text] [Related]

  • 17. Proglumide selectively potentiates supraspinal mu 1 opioid analgesia in mice.
    Bodnar RJ, Paul D, Pasternak GW.
    Neuropharmacology; 1990 May 11; 29(5):507-10. PubMed ID: 2162497
    [Abstract] [Full Text] [Related]

  • 18. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F, Smadja C, Roques BP.
    J Pharmacol Exp Ther; 1994 Dec 11; 271(3):1127-34. PubMed ID: 7996417
    [Abstract] [Full Text] [Related]

  • 19. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ, Nunan L, Porreca F.
    J Pharmacol Exp Ther; 1989 May 11; 249(2):462-9. PubMed ID: 2566676
    [Abstract] [Full Text] [Related]

  • 20. [High and low frequency electroacupuncture analgesia are mediated by different types of opioid receptors at spinal level: a cross tolerance study].
    Sun SL, Han JS.
    Sheng Li Xue Bao; 1989 Aug 11; 41(4):416-20. PubMed ID: 2574915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.